當前位置:深圳遠揚化學技術有限公司>>技術文章>>西格列汀全套雜質
西格列汀適應癥及前景:磷酸西格列汀片是*個批準用于治療2型糖尿病的DPP-4抑制劑,可抑制β細胞凋亡,促進β細胞新生,增加2型糖尿病患者β細胞數(shù)量,明顯降低患者血糖,并且對磺脲類藥物失效的患者仍有顯著的降糖作用。磷酸西格列汀片主要通過配合運動和飲食控制實現(xiàn)對2型糖尿病患者的血糖控制。
經(jīng)上市后超過上千萬余張?zhí)幏降臋z驗,西格列汀進一步顯示出強有效的降糖療效和優(yōu)異的安全性,成為降糖藥物中耀眼的新星。西格列汀的巨大成功也獲得了醫(yī)藥科技界同仁的廣泛贊譽,各種獎項接踵而至,其中zui值得一提的是2007年度的“愛迪生獎”和“蓋倫獎”等殊榮。2009 3月21日,中國國家食品藥品監(jiān)督管理局已正式批準其捷諾維(磷酸西格列?。┰谥袊鲜?, 使之成為國內市場上*用于治療2型糖尿病的(DPP-4)抑制劑。
深圳遠揚化學技術有限公司提供西格列汀全套雜質,隨貨提供結構確認圖譜,純度高,穩(wěn)定性好, (詳情請點擊本頁標題下方“進入該公司展臺” 查看我司信息)。
Sitagliptin | (R)-3-ami-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one |
Sitagliptin Impurity 1 | (R)-3-((tert-butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid |
Sitagliptin Impurity 2 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid |
Sitagliptin Impurity 3 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid |
Sitagliptin Impurity 4 | (S)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid |
Sitagliptin Impurity 5 | (R)-methyl 3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoate |
Sitagliptin Impurity 6 | (R)-methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate |
Sitagliptin Impurity 7 | (R)-3-amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one |
Sitagliptin Impurity 8 | (R)-3-amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one |
Sitagliptin Impurity 9 | (R)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one |
Sitagliptin Impurity 10 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid |
Sitagliptin Impurity 11 | (R)-tert-butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate |
Sitagliptin Impurity 12 | (S)-3-ami-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one |
Sitagliptin Impurity 13 | 1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione |
Sitagliptin Impurity 14 | (Z)-3-ami-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one |
Sitagliptin Impurity 15 | (R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid |
Sitagliptin Impurity 16 | (E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one |
Sitagliptin Impurity 17 | (E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one |
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內容的真實性、準確性和合法性由相關企業(yè)負責,化工儀器網(wǎng)對此不承擔任何保證責任。
溫馨提示:為規(guī)避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。